SCHEMBL3636294

SCHEMBL3636294

CCC(C#N)c1cccc(C(=O)Nc2cccc(Oc3ccc(N)nc3)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 15/20 0.53
THRB P10828 1/20 0.46
NR1H4 Q96RI1 2/20 0.46
FABP1 P07148 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3640649 0.88 BRAF (0.47) CDK8
SCHEMBL3638532 0.86 FFAR1 (0.47) THRBNR1H4FABP1
SCHEMBL3641158 0.82 MEN1 (0.47) CDK8NR1H4
SCHEMBL2335120 0.80 FNTA (0.44) THRBNR1H4
SCHEMBL2857455 0.79 BRAF (0.68) CDK8
SCHEMBL2334149 0.77 POLB (0.47)
SCHEMBL2851251 0.76 CDK8 (0.52) CDK8
SCHEMBL2338143 0.76 KMT2A (0.58) NR1H4
SCHEMBL2857312 0.75 CDK8 (0.79) CDK8
SCHEMBL3639218 0.75 KDR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2162445-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-03-17 EP disclosed
WO-2008150015-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-11 WO disclosed